2/25/2013

Affymax and Takeda Pharmaceutical have recalled Omontys, or peginesatide, following reports of serious allergic reactions and three deaths. The drug is used to treat anemia in patients undergoing kidney dialysis. Three deaths and 16 other cases of severe reactions have been reported, according to the FDA.

Related Summaries